Chiara Bardella

2.4k total citations
20 papers, 1.0k citations indexed

About

Chiara Bardella is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Chiara Bardella has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Chiara Bardella's work include Cancer, Hypoxia, and Metabolism (10 papers), Glioma Diagnosis and Treatment (6 papers) and Liver physiology and pathology (4 papers). Chiara Bardella is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Glioma Diagnosis and Treatment (6 papers) and Liver physiology and pathology (4 papers). Chiara Bardella collaborates with scholars based in United Kingdom, United States and Italy. Chiara Bardella's co-authors include Ian Tomlinson, Patrick J. Pollard, Maria Flavia Di Renzo, Daniel Krell, Paul Mulholland, Martina Olivero, Georgios Solomou, Michele De Bortoli, Veronica J. Buckle and Jill M. Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Chiara Bardella

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Bardella United Kingdom 17 663 436 129 122 101 20 1.0k
Jessica E.S. Shay United States 11 903 1.4× 932 2.1× 183 1.4× 107 0.9× 128 1.3× 22 1.5k
Astrid Katzer Germany 20 552 0.8× 343 0.8× 134 1.0× 94 0.8× 110 1.1× 28 891
Cindy Hodakoski United States 10 864 1.3× 315 0.7× 203 1.6× 93 0.8× 113 1.1× 11 1.2k
Caroline Wigerup Sweden 15 525 0.8× 584 1.3× 218 1.7× 45 0.4× 120 1.2× 16 999
Efstathia Giannopoulou Greece 20 561 0.8× 277 0.6× 297 2.3× 64 0.5× 129 1.3× 44 1.0k
Matthew Knabel United States 4 851 1.3× 786 1.8× 125 1.0× 41 0.3× 76 0.8× 5 1.3k
Lei Zhan China 13 666 1.0× 364 0.8× 190 1.5× 47 0.4× 131 1.3× 22 1.1k
Joo Heon Kim South Korea 10 748 1.1× 251 0.6× 204 1.6× 87 0.7× 86 0.9× 11 1.0k
Gabriele D. Maurer Germany 17 671 1.0× 385 0.9× 214 1.7× 289 2.4× 83 0.8× 36 1.2k
Hanhua Huang United States 9 595 0.9× 262 0.6× 182 1.4× 47 0.4× 95 0.9× 14 869

Countries citing papers authored by Chiara Bardella

Since Specialization
Citations

This map shows the geographic impact of Chiara Bardella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Bardella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Bardella more than expected).

Fields of papers citing papers by Chiara Bardella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Bardella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Bardella. The network helps show where Chiara Bardella may publish in the future.

Co-authorship network of co-authors of Chiara Bardella

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Bardella. A scholar is included among the top collaborators of Chiara Bardella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Bardella. Chiara Bardella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Solomou, Georgios, et al.. (2023). Mutant IDH in Gliomas: Role in Cancer and Treatment Options. Cancers. 15(11). 2883–2883. 27 indexed citations
3.
Rabe, Patrick, I.J. Clifton, Fräser A. Armstrong, et al.. (2022). Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors. Nature Communications. 13(1). 4785–4785. 37 indexed citations
4.
Solomou, Georgios, et al.. (2021). Advances in Research of Adult Gliomas. International Journal of Molecular Sciences. 22(2). 924–924. 51 indexed citations
5.
Walsby-Tickle, John, Joan Gannon, Chiara Bardella, et al.. (2020). Anion-exchange chromatography mass spectrometry provides extensive coverage of primary metabolic pathways revealing altered metabolism in IDH1 mutant cells. Communications Biology. 3(1). 247–247. 55 indexed citations
6.
Lee, Lennard Y. W., Thomas Starkey, Sujata Biswas, et al.. (2018). Serum- and Glucocorticoid-induced Kinase Sgk1 Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis. Clinical Cancer Research. 25(2). 629–640. 24 indexed citations
7.
Bardella, Chiara, et al.. (2018). The role of inflammation in subventricular zone cancer. Progress in Neurobiology. 170. 37–52. 18 indexed citations
8.
Irshad, Shazia, Mukesh Bansal, Paolo Guarnieri, et al.. (2017). BMP and Notch interaction in CRC subtypes. 19 indexed citations
9.
Irshad, Shazia, Mukesh Bansal, Paolo Guarnieri, et al.. (2017). Bone morphogenetic protein and Notch signalling crosstalk in poor‐prognosis, mesenchymal‐subtype colorectal cancer. The Journal of Pathology. 242(2). 178–192. 37 indexed citations
10.
Krell, Daniel, Paul Mulholland, Justin Stebbing, Ian Tomlinson, & Chiara Bardella. (2015). HOT mutation screening in human glioblastomas. Future Science OA. 1(3). 1 indexed citations
11.
Krell, Daniel, Paul Mulholland, Adam E. Frampton, et al.. (2013). IDH Mutations in Tumorigenesis and Their Potential Role As Novel Therapeutic Targets. Future Oncology. 9(12). 1923–1935. 48 indexed citations
12.
Bardella, Chiara, Martina Olivero, Annalisa Lorenzato, et al.. (2012). Cells Lacking the Fumarase Tumor Suppressor Are Protected from Apoptosis through a Hypoxia-Inducible Factor-Independent, AMPK-Dependent Mechanism. Molecular and Cellular Biology. 32(15). 3081–3094. 29 indexed citations
13.
Schödel, Johannes, Chiara Bardella, Lina K. Sciesielski, et al.. (2012). Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression. Nature Genetics. 44(4). 420–425. 114 indexed citations
14.
Bardella, Chiara, Patrick J. Pollard, & Ian Tomlinson. (2011). SDH mutations in cancer. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1807(11). 1432–1443. 308 indexed citations
15.
Krell, Daniel, et al.. (2011). Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma. PLoS ONE. 6(5). e19868–e19868. 78 indexed citations
16.
Costa, Barbara, Daniela Dettori, Annalisa Lorenzato, et al.. (2010). Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis. The FASEB Journal. 24(8). 2680–2688. 13 indexed citations
17.
Cardamone, Maria Dafne, Chiara Bardella, Arantxa Gutiérrez, et al.. (2009). ERα as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells. Proceedings of the National Academy of Sciences. 106(18). 7420–7425. 36 indexed citations
18.
Bardella, Chiara, Daniela Dettori, Martina Olivero, et al.. (2007). The Therapeutic Potential of Hepatocyte Growth Factor to Sensitize Ovarian Cancer Cells to Cisplatin and Paclitaxel In vivo. Clinical Cancer Research. 13(7). 2191–2198. 24 indexed citations
19.
Coltella, Nadia, Andrea Rasola, Chiara Bardella, et al.. (2006). p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy‐induced apoptosis. International Journal of Cancer. 118(12). 2981–2990. 31 indexed citations
20.
Bardella, Chiara, Barbara Costa, Piera Maggiora, et al.. (2004). Truncated RON Tyrosine Kinase Drives Tumor Cell Progression and Abrogates Cell-Cell Adhesion Through E-Cadherin Transcriptional Repression. Cancer Research. 64(15). 5154–5161. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica E.S. Shay Breakdown of academic impact, for papers by Astrid Katzer Breakdown of academic impact, for papers by Cindy Hodakoski Breakdown of academic impact, for papers by Caroline Wigerup Breakdown of academic impact, for papers by Efstathia Giannopoulou Breakdown of academic impact, for papers by Matthew Knabel Breakdown of academic impact, for papers by Lei Zhan Breakdown of academic impact, for papers by Joo Heon Kim Breakdown of academic impact, for papers by Gabriele D. Maurer Breakdown of academic impact, for papers by Hanhua Huang
Rankless by CCL
2026